Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2009

01-08-2009 | Breast Oncology

A Prospective, Multi-Institutional Study of Adjuvant Radiotherapy After Resection of Malignant Phyllodes Tumors

Authors: Richard J. Barth Jr., MD, Wendy A. Wells, MD, Sandra E. Mitchell, MD, Bernard F. Cole, PhD

Published in: Annals of Surgical Oncology | Issue 8/2009

Login to get access

Abstract

Background

Malignant phyllodes tumors of the breast are unusual neoplasms, with an incidence of approximately 500 cases annually in the United States. Published local recurrence rates after margin-negative breast-conserving resections of borderline malignant and malignant phyllodes tumors are unacceptably high, at 24 and 20%, respectively. It is uncertain whether radiotherapy after resection of phyllodes tumors is beneficial.

Methods

We prospectively enrolled patients who were treated with a margin-negative breast-conserving resection of borderline malignant or malignant phyllodes tumors to adjuvant radiotherapy. The primary endpoint was local recurrence.

Results

Forty-six women were treated at 30 different institutions. The mean patient age was 49 years (range, 18–76 years). Thirty patients (65%) had malignant phyllodes tumors; the rest were borderline malignant. The mean tumor diameter was 3.7 cm (range, .8–11 cm). Eighteen patients had a negative margin on the first excision. The median size of the negative margin was .35 cm (range, <.1–2 cm). Twenty-eight patients underwent a re-excision because of positive margins in the initial resection. Two patients died of metastatic phyllodes tumor. During a median follow-up of 56 months (range, 12–129 months), none of the 46 patients developed a local recurrence (local recurrence rate, 0%; 95% confidence interval, 0–8).

Conclusions

Margin-negative resection combined with adjuvant radiotherapy is very effective therapy for local control of borderline and malignant phyllodes tumors. The local recurrence rate with adjuvant radiotherapy was significantly less than that observed in reported patients treated with margin-negative resection alone.
Appendix
Available only for authorised users
Literature
2.
go back to reference Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer. 1996;77:910–6.PubMedCrossRef Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer. 1996;77:910–6.PubMedCrossRef
3.
go back to reference Asoglu O, Ugurlu M, Blanchard K, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:1011–7.PubMedCrossRef Asoglu O, Ugurlu M, Blanchard K, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:1011–7.PubMedCrossRef
4.
go back to reference Belkacemi Y, Bousquet G, Marsiglia H, et al. Phyllodes tumors of the breast. Int J Radiat Oncol Biol Phys. 2008;70:492–500.PubMed Belkacemi Y, Bousquet G, Marsiglia H, et al. Phyllodes tumors of the breast. Int J Radiat Oncol Biol Phys. 2008;70:492–500.PubMed
5.
go back to reference Macdonald O, Lee C, Tward J, Chappel C, Gaffney D. Malignant phyllodes tumor of the female breast. Cancer. 2006;107:2127–33.PubMedCrossRef Macdonald O, Lee C, Tward J, Chappel C, Gaffney D. Malignant phyllodes tumor of the female breast. Cancer. 2006;107:2127–33.PubMedCrossRef
6.
go back to reference Barth R. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57:291–5.PubMedCrossRef Barth R. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57:291–5.PubMedCrossRef
7.
go back to reference World Health Organization. Histologic typing of breast tumors. Tumori. 1982;68:181–98. World Health Organization. Histologic typing of breast tumors. Tumori. 1982;68:181–98.
8.
go back to reference de Roos W, Kaye P, Dent D. Factors leading to local recurrence or death after surgical resection of phyllodes tumors of the breast. Br J Surg. 1999;86:396–9.PubMedCrossRef de Roos W, Kaye P, Dent D. Factors leading to local recurrence or death after surgical resection of phyllodes tumors of the breast. Br J Surg. 1999;86:396–9.PubMedCrossRef
9.
go back to reference Zissis C, Apostolikas N, Konstantinidou A, Griniatsos J, Vassilopoulos P. The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat. 1998;48:205–10.PubMedCrossRef Zissis C, Apostolikas N, Konstantinidou A, Griniatsos J, Vassilopoulos P. The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat. 1998;48:205–10.PubMedCrossRef
10.
go back to reference Holthouse D, Smith P, Naunton-Morgan R, Minchin D. Cystosarcoma phyllodes: the western Australian experience. Aust N Z J Surg. 1999;69:635–8.PubMedCrossRef Holthouse D, Smith P, Naunton-Morgan R, Minchin D. Cystosarcoma phyllodes: the western Australian experience. Aust N Z J Surg. 1999;69:635–8.PubMedCrossRef
11.
go back to reference Chaney A, Pollack A, Mcneese M, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89:1502–11.PubMedCrossRef Chaney A, Pollack A, Mcneese M, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89:1502–11.PubMedCrossRef
12.
go back to reference Kapiris I, Nasir N, A’hern R, Healy V, Gui G. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumors of the breast. Eur J Surg Oncol. 2001;27:723–30.PubMedCrossRef Kapiris I, Nasir N, A’hern R, Healy V, Gui G. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumors of the breast. Eur J Surg Oncol. 2001;27:723–30.PubMedCrossRef
13.
go back to reference Kok K, Telesinghe P, Yapp S. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13 year experience. J R Coll Surg Edinb. 2001;46:198–201.PubMed Kok K, Telesinghe P, Yapp S. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13 year experience. J R Coll Surg Edinb. 2001;46:198–201.PubMed
14.
go back to reference Fou A, Schnabel F, Hamele-Bena D, et al. Long term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg. 2006;192:492–5.PubMedCrossRef Fou A, Schnabel F, Hamele-Bena D, et al. Long term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg. 2006;192:492–5.PubMedCrossRef
15.
go back to reference Abdalla H, Sakr M. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18:125–33.PubMed Abdalla H, Sakr M. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18:125–33.PubMed
16.
go back to reference Taira N, Takabatake D, Aogi K, et al. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37:730–6.PubMedCrossRef Taira N, Takabatake D, Aogi K, et al. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37:730–6.PubMedCrossRef
17.
go back to reference Barrio A, Clark B, Goldberg J, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14:2961–70.PubMedCrossRef Barrio A, Clark B, Goldberg J, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14:2961–70.PubMedCrossRef
18.
go back to reference Lenhard M, Kahlert S, Himsl I, et al. Phyllodes tumor of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol. 2007;138:217–21.PubMedCrossRef Lenhard M, Kahlert S, Himsl I, et al. Phyllodes tumor of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol. 2007;138:217–21.PubMedCrossRef
20.
go back to reference Moffat C, Pinder S, Dixon A, et al. Phyllodes tumors of the breast: a clinicopathological review of 32 cases. Histopathology. 1995;27:205–18.PubMedCrossRef Moffat C, Pinder S, Dixon A, et al. Phyllodes tumors of the breast: a clinicopathological review of 32 cases. Histopathology. 1995;27:205–18.PubMedCrossRef
21.
go back to reference Pezner R, Schultheiss T, Paz I. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008;71:710–13.PubMed Pezner R, Schultheiss T, Paz I. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008;71:710–13.PubMed
22.
go back to reference Chen W, Cheng S, Tzen C, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91:185–94.PubMedCrossRef Chen W, Cheng S, Tzen C, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91:185–94.PubMedCrossRef
23.
24.
go back to reference Mangi A, Smith B, Gadd M, et al. Surgical management of phyllodes tumors. Arch Surg. 1999;134:487–93.PubMedCrossRef Mangi A, Smith B, Gadd M, et al. Surgical management of phyllodes tumors. Arch Surg. 1999;134:487–93.PubMedCrossRef
25.
go back to reference Clark M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106. Clark M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106.
26.
go back to reference Hoover H, Testioreanu A, Ketcham A. Metastatic cystosarcoma phyllodes in an adolescent girl. Ann Surg. 1975;181:279–82.PubMedCrossRef Hoover H, Testioreanu A, Ketcham A. Metastatic cystosarcoma phyllodes in an adolescent girl. Ann Surg. 1975;181:279–82.PubMedCrossRef
27.
go back to reference Burton G, Hart L, Leight G, et al. Cystosarcoma phyllodes, effective treatment with chemotherapy. Cancer. 1989;63:2088–92.PubMedCrossRef Burton G, Hart L, Leight G, et al. Cystosarcoma phyllodes, effective treatment with chemotherapy. Cancer. 1989;63:2088–92.PubMedCrossRef
28.
go back to reference Thomas A, Ashworth B, Blake P. Regression of recurrent cystosarcoma phyllodes tumor after neutron treatment. Br J Radiol. 1984;57:926–9.PubMed Thomas A, Ashworth B, Blake P. Regression of recurrent cystosarcoma phyllodes tumor after neutron treatment. Br J Radiol. 1984;57:926–9.PubMed
29.
go back to reference Allen R, Nixon D, York M, et al. Successful chemotherapy for cystosarcoma phyllodes. Arch Intern Med. 1985;145:1127–8.PubMedCrossRef Allen R, Nixon D, York M, et al. Successful chemotherapy for cystosarcoma phyllodes. Arch Intern Med. 1985;145:1127–8.PubMedCrossRef
30.
go back to reference Turalba C, El-Mahdi A, Ladga L. Fatal metastatic cystosarcoma phyllodes. J Surg Oncol. 1986;33:176–81.PubMedCrossRef Turalba C, El-Mahdi A, Ladga L. Fatal metastatic cystosarcoma phyllodes. J Surg Oncol. 1986;33:176–81.PubMedCrossRef
31.
go back to reference Stockdale A, Leader M. Case report: phyllodes tumor of the breast: response to radiotherapy. Clin Radiol. 1987;38:287.PubMedCrossRef Stockdale A, Leader M. Case report: phyllodes tumor of the breast: response to radiotherapy. Clin Radiol. 1987;38:287.PubMedCrossRef
32.
go back to reference Lindquist K, van Heerden J, Wieland L, et al. Recurrent and metastatic cystosarcoma phyllodes. Am J Surg. 1982;144:341–3.PubMedCrossRef Lindquist K, van Heerden J, Wieland L, et al. Recurrent and metastatic cystosarcoma phyllodes. Am J Surg. 1982;144:341–3.PubMedCrossRef
33.
go back to reference Reinfuss M, Mitus J, Smolak K, Stelkmach A. Malignant phyllodes tumors of the breast. Eur J Cancer. 1993;29A:1252–6. Reinfuss M, Mitus J, Smolak K, Stelkmach A. Malignant phyllodes tumors of the breast. Eur J Cancer. 1993;29A:1252–6.
34.
go back to reference Joshi S, Sharma D, Bahadur A, et al. Cystosarcoma phyllodes: our institutional experience. Australas Radiol. 2003;47:434–7.PubMedCrossRef Joshi S, Sharma D, Bahadur A, et al. Cystosarcoma phyllodes: our institutional experience. Australas Radiol. 2003;47:434–7.PubMedCrossRef
35.
go back to reference Kleer C, Giordano T, Braun T, Oberman H. Pathologic, immunohistochemical and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 2001;14:185–90.PubMedCrossRef Kleer C, Giordano T, Braun T, Oberman H. Pathologic, immunohistochemical and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 2001;14:185–90.PubMedCrossRef
36.
go back to reference Soumarova R, Seneklova Z, Horova H, et al. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes—treatment results. Arch Gynecol Obstet. 2004;269:278–81.PubMedCrossRef Soumarova R, Seneklova Z, Horova H, et al. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes—treatment results. Arch Gynecol Obstet. 2004;269:278–81.PubMedCrossRef
37.
38.
go back to reference Chatson G, Anderson C, Berman M, et al. Phyllodes tumors. Contemp Surg. 1992;40:36–41. Chatson G, Anderson C, Berman M, et al. Phyllodes tumors. Contemp Surg. 1992;40:36–41.
39.
go back to reference Chaney A, Pollack A, McNeese M, Zagars G. Adjuvant radiation therapy for phyllodes tumors of the breast. Radiat Oncol Investig. 1998;6:264–7.PubMedCrossRef Chaney A, Pollack A, McNeese M, Zagars G. Adjuvant radiation therapy for phyllodes tumors of the breast. Radiat Oncol Investig. 1998;6:264–7.PubMedCrossRef
40.
go back to reference Tan P, Jayabaskar T, Chuah K, et al. Phyllodes tumors of the breast, the role of pathologic parameters. Am J Clin Pathol. 2005;123:529.PubMedCrossRef Tan P, Jayabaskar T, Chuah K, et al. Phyllodes tumors of the breast, the role of pathologic parameters. Am J Clin Pathol. 2005;123:529.PubMedCrossRef
41.
go back to reference Vicini F, Beitsch P, Quiet C, et al. Three year analysis of treatment efficacy, cosmesis and toxicity in the American Society of Breast Surgeons Mammosite Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Cancer. 2008;112:758–66.PubMedCrossRef Vicini F, Beitsch P, Quiet C, et al. Three year analysis of treatment efficacy, cosmesis and toxicity in the American Society of Breast Surgeons Mammosite Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Cancer. 2008;112:758–66.PubMedCrossRef
Metadata
Title
A Prospective, Multi-Institutional Study of Adjuvant Radiotherapy After Resection of Malignant Phyllodes Tumors
Authors
Richard J. Barth Jr., MD
Wendy A. Wells, MD
Sandra E. Mitchell, MD
Bernard F. Cole, PhD
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0489-2

Other articles of this Issue 8/2009

Annals of Surgical Oncology 8/2009 Go to the issue